Irrelevant in the scheme of things16 May 2024 15:13
I've read through the RNS and the key point is, as far as I can tell, that CL17 has agreed to pay the receiver €170,000 to give up their 30% rights in any settlement, which looks pretty good since 30% of €700,000 is €210,000. CL17 are betting that the Venice Court of Appeal sets the hearing date to approve the settlement before it issues its ruling on the appeal, otherwise the offer of €700,000 will be void. If you subtract the €170,000 paid to the receiver, from the €700,000 expected settlement, CL17 will be in pocket by around €530,000 once they receive the settlement funds.
CL17 are still pursuing the main defendant and one other for the remaining €5.575 million since they aren't included in the appeal, or the €700,000 settlement. It's hard to know if CL17 will ever be successful in recovering the outstanding €5.575 million, so far they appear to be struggling to persuade these two defendants to pay up.
The reason I believe this to be irrelevant, is because at best it'll cover QBT's operating costs for a couple of years, should they also receive the €5,575,000, but it'll make no difference when it comes to the success or failure of QBT's product offerings. The only thing that'll save QBT is if their innovations show real world efficiency improvements matching those seen in the lab.